Replies to post #1059 on Amarantus Bioscience Holdings Inc (AMBS)

[PENNYS ToMILLIONS]

How is it you have owned this Co. since last year and you know nothing about them? I know you know that this Co. is not known on investors hub B/c you are the poster who has posted the most and that has only been 25o times in just under a year. Don't worry...this will all work out for you ;-)

[PENNYS ToMILLIONS]

I know you know the financing they have in place but here is a review of it if you forgot

Amarantus BioSciences Announces Close of $10M
Equity Funding Facility with Centurion Private
Equity, LLC
SUNNYVALE, CA - October 13, 2011 – Amarantus Biosciences, Inc. (OTCBB: AMBS) a
biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic
protein that addresses an underlying form of cell death known as apoptosis, announced
today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC
(“Centurion”). The Company will have the ability to draw down on this facility over the course
of the next 36 months in tranches of up $750,000

[PENNYS ToMILLIONS]

and here is some more $$$

Amarantus BioSciences Receives Grant from Brewer Sports International for Traumatic Brain Injury
SUNNYVALE, CA and MINNEAPOLIS, MN– November 30, 2011 – Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF), a first-in-class disease–modifying therapeutic protein, today announced a commitment by Brewer Sports International (BSI) to fund a pre-clinical study evaluating MANF’s potential as a treatment for Traumatic Brain Injury (TBI). This funding will support the collaboration recently announced between Amarantus and Banyan Biomarkers.